MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 99 (3) , 445-453
- https://doi.org/10.1016/0041-008x(89)90152-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activationJournal of Neuroscience, 1988
- The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsBrain Research, 1988
- Glutamate Antagonist Therapy Reduces Neurologic Deficits Produced by Focal Central Nervous System IschemiaArchives of Neurology, 1988
- Non-competitive antagonists of excitatory amino acid receptorsTrends in Neurosciences, 1987
- Excitatory amino acids in the brain - focus on NMDA receptorsTrends in Neurosciences, 1987
- The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐d‐aspartate receptor in rat brainBritish Journal of Pharmacology, 1987
- Systemic administration of MK-801 prevents neuronal degeneration in rat brainNeuroscience Letters, 1987
- Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[3H]Glutamate BindingJournal of Neurochemistry, 1987
- Neurotransmitter glutamate: its clinical importanceActa Neurologica Scandinavica, 1986
- The excitant amino acids glutamic and aspartic acid as transmitter candidates in the vertebrate central nervous systemProgress in Neurobiology, 1978